Summary
The clearest overlap between Semax and Thymosin Beta-4 is that both converge around Signaling modulator. Their typical research and application settings separate fairly clearly: Semax is more often discussed in the realm of Neurology and brain health and Ophthalmology, whereas Thymosin Beta-4 is more often associated with the realm of Musculoskeletal health, Cardiovascular health, and Dermatology and aesthetics. Both appear to work through Signaling modulator, but the functional emphasis still separates, with Semax leaning toward Neuroprotection and cognition and Thymosin Beta-4 leaning toward Tissue repair and healing, Angiogenesis modulation, and Anti-inflammatory. Semax has a more synthetic analog origin, while Thymosin Beta-4 is closer to natural endogenous background with Semax approved for Research use only and Thymosin Beta-4 in Clinical phase 2. Thymosin Beta-4 incorporates acetylation features that are not part of Semax.